✦ LIBER ✦

Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma

✍ Scribed by Kakolyris, S.; Agelidou, A.; Androulakis, N.; Tsaroucha, E.; Kouroussis, Ch.; Agelidou, M.; Karvounis, N.; Veslemes, M.; Christophylakis, Ch.; Argyraki, A.; Geroyianni, A.; Georgoulias, V.

Book ID: 119319390
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 154 KB
Volume: 53
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan plus cisplatin chemotherapy f

Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer

✍ Hanan A. Wahba; Amal A. Halim; Hend A. El-Hadaad 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 211 KB

Etoposide plus cisplatin followed by con

Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study

✍ Xenidis, N.; Kotsakis, A.; Kalykaki, A.; Christophyllakis, Ch.; Giassas, S.; Ken 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Weekly alternating therapy with irinotec

Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma

✍ William N. William Jr; James Uyeki; Faye M. Johnson; Lei Feng; Beverly O. Peeple 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor

P-62 Phase II trial of irinotecan plus c

P-62 Phase II trial of irinotecan plus cisplatin after cisplatin plus etoposide and concurrent thoracic radiotherapy (TRT) in small cell lung cancer (SCLC) patients with limited disease: West Japan Thoracic Oncology Group 9902

✍ Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Randomized trial comparing postoperative

Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer

✍ K. M. W. Pisters; M. G. Kris; R. J. Gralla; B. Hilaris; P. M. McCormack; M. S. B 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

This prospective randomized trial was performed to determine whether postoperative chemotherapy with vindesine and cisplatin could lengthen time to progression and overall survival in stage I11 (Tl-3N2MO) non-small cell lung cancer (NSCLC) patients. Seventy-two patients were entered; 36 were randomi